Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152)

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4433-4442

  Griffin, Matthew D ^a,b   Hong, David K ^a   Holman, Philmore O ^c   Lee, Kyung Mi ^a   Whitters, Matthew J ^d   O'Herrin, Sean M ^a   Fallarino, Francesca ^a   Collins, Mary ^d   Segal, David M ^e   Gajewski, Thomas F ^a   Kranz, David M ^c   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d PFIZER INC   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOMODULATION; LYMPHOCYTE MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 10744233636     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4433     Document Type: Article

References (69)

1. Van Parijs, M., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
2. Healy, J. I., and C. C. Goodnow. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:645.
3. Scharenberg, A. M., and J.-P. Kinet. 1996. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 87:961.
4. Chen, J.-J., Y. Sun, and G. J. Nabel. 1998. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282:1714.
5. Straus, S. E., M. Sneller, M. J. Lenardo, J. M. Puck, and W. Strober. 1999. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann. Int. Med. 130:591.
6. Conner, H., H. Rau, P. G. Walfish, J. Braun, T. Siegmund, R. Finke, J. Herwig, K. H. Usadel, and K. Badenhoop. 1997. CTLA4 alanine-17 confers genetic susceptibility to Grave's disease and to type I diabetes mellitus. J. Clin. Endocrinol. Methods 82:143.
7. Ellis, J. H., M. N. Burden, D. V. Vinogradov, C. Linge, and J. S. Crowe. 1996. Interactions of CD80 and CD86 with CD28 and CTLA4. J. Immunol. 56:2700.
8. Van der Merwe, P. A., D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis. 1997. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:393.
9. Walunus, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
10. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
11. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
12. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
13. Sperling, A. I., and J. A. Bluestone. 1996. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153:155.
14. Bluestone J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989.
15. Brunner, M. C., C. A. Chambers, F. K.-M. Chan, J. Hanke, A. Winto, and J. P. Allison. 1999. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162:5813.
16. L induction. J. Immunol. 160:12.
17. Fallarino, F., P. E. Fields, and T. F. Gajewski. 1998. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188:205.
18. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorder with early lethality in mice deficient in Ctla-4. Science 270:985.
19. Tivol, E. A., F. Boriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
20. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
21. McCoy, K., M. Camberis, and G. Le Gros. 1997. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 186:183.
22. Karindikar N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Blueslone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
23. Lühder, F., P. Höglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
24. Lin, H., J. C. Rathmell, G. S. Gray, C. B. Thompson, J. M. Leiden, and M.-L. Alegre. 1998. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188:199.
25. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance requires CTLA-4 engagement. Immunity 6:411.
26. Walunas, T. L., and J. A. Bluestone. 1998. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160:3855.
27. Issazadeh, S., M. Zhang, M. H. Sayegh, and S. J. Khoury. 1999. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. J. Immunol. 162:761.
28. Zheng, X. X., T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom. 1999. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J. Immunol. 162:4983.
29. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S.-M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science 242:423.
30. Whitlow, M., and D. Filpula. 1991. Single-chain Fv proteins and their fusion proteins. Methods 2:97.
31. Gilliland L. K., N. A. Norris, H. Marquardt, T. T. Tsu, M. S. Hayden, M. G. Neubauer, D. E. Yelton, R. S. Mittler, and J. A. Ledbetter. 1996. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments. Tissue Antigens 47:1.
32. Gajewski, T. F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol. 156:2909.
33. George, A. J., J. A. Titus, C. R. Jost, I. Kurucz, P. Perez, S. M. Andrew, P. J. Nicholls, J. S. Huston, and D. M. Scgal. 1994. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. J. Immunol. 152: 1802.
34. Sochin, B. A., and D. M. Kranz. 1993. Binding affinity and inhibitory properties of a single-chain anti-T cell receptor antibody. J. Biol. Chem. 268:25722.
35. 2 molecule produced in mammalian cells redirects lysis by activated CTL. Mol. Immunol. 33:211.
36. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
37. + splenic T cells after CD28 receptor ligation. J. Immunol. 154:985.
38. Seed, B. 1987. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 329:840.
39. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
40. Smith, D. M., J. A. Bluestone, D. R. Jeyarajah, M. H. Newberg, V. H. Engelhard, J. R. Thistlethwaite, Jr., and E. S. Woodle. 1994. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I. J. Immunol. 153:1054.
41. Malissen, M. T. Hunkapiller, and L. E. Hood. 1983. Nucleotide sequence of light chain gene of the mouse I-A subregion I-β-d. Science 221:750.
42. Choi, E., K. McIntyre, R. N. Germain, and Seidman J. G. 1983. Murine I-Aβ chain polymorphism: nucleotide sequences of three allelic I-Aβ genes. Science 221:283.
43. Benoist, C. O., D. J. Mathis, M. R. Kanter, V. E. Williams II, and H. O. McDevitt. 1983. Regions of allelic hypervariability in the murine A-alpha immune response gene. Cell 34:169.
44. Chen, C., and H. Okayama. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7:2745.
45. Heemskerk, M. H., B. Blom, G. Nolan, A. P. Stegmann, A. Q. Bakker, K. Weijer, P. C. Res. and H. Spits. 1997. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix faetor Id3. J. Exp. Med. 186:1597.
46. Bruce, J., F. W. Symington, T. J. McKearn, J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127:2496.
47. Kappler, J. W., B. Skidmore, J. While, P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
48. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. McDonald. 1985. Expression of IL-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
49. Sarmiento, M., D. P. Dialynas, D. W. Lancki, K. A. Wall, M. I. Lorber, M. R. Loken, and F. W. Fitch. 1980. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135.
50. Dent, A. L. L. A. Matis, F. H. Hooshmand, S. M. Widacki, J. A. Bluestone, and S. M. Hedrick. 1990. Self-reactive γ-δ T cells are eliminated in the thymus. Nature 343:714.
51. Calvo, C. R., D. Amsen, and A. M. Kruisbeek. 1997. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, hut does not affect phosphorylation of T cell receptor ζ and ZAP70. J. Exp. Med. 186:1645.
52. + T cells. Eur. J. Immunol. 28:3137.
53. + T cell help. J. Exp. Med. 189:1157.
54. Saverino, D., C. Tenca, D. Zarcone, A. Merlo, A. M. Megiovanni, M. T. Valle, F. Manca, C. E. Grossi, and E. Ciccone. 1999. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J. Immunol. 162:651.
55. Khattri, R., J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone. 1998. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of TH2 responses. J. Immunol. 162:5784.
56. Metz, D. P., D. L. Farber, T. Taylor, and K. Bottomly. 1998. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation. J. Immunol. 161:5855.
57. Alegre, M.-L., H. Shiels, C. B. Thompson, and T. F. Gajewski. 1998. Expression and function of CTLA-4 in Th1 and Th2 cells. J. Immunol. 161:3347.
58. Lee, K.-M., E. Chaung, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C.B. Thompson, and J.A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282:2263.
59. Zhang, W., J. Sloane-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase subslrale that links T cell receptor to cellular activation. Cell 92:83.
60. lo thymocytes in vivo. Science 250: 1720.
61. Chaudhary, V. K., C. Queen, R. P. Jughans, T. A. Waldmann, D. J. FitzGerald, and I. Pastan. 1989. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomanas endotoxin. Nature 339:394.
62. Winberg, G., L. S. Grosmarie, K. Klussman, M. S. Hayden, H. P. Fell, J. A. Ledbetter, and R. S. Mittler. 1996. Surface expression of CD28 single chain Fv for costimulation by tumor cells. Immunol. Rev. 153:209.
63. Wu, Y., Y. Guo, A. Huang, P. Zheng, and Y. Liu. 1997. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185:1327.
64. Zheng, P., Y. Wu, Y. Guo, C. Lee, and Y. Lee. 1998. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc. Natl. Acad. Sci. USA 95:6284.
65. + T cells. Immunity 7:885.
66. Waterhouse, P., L. E. M. Marengère, H.-W. Mittr̈cker, and T. W. Mak. 1996. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153: 183.
67. Marengère, L. E. M., P. Waterhouse, G. S. Duncan, H.-W. Mittrücker, G.-S. Feng, and T. W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP associated with CTLA-4. Science 272:1170.
68. Cilio, C.M., M.R. Daws, A. Malashicheva, C.L. Sentman, and D. Holmberg. 1998. Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-medialed depletion of thymocytes. J. Exp. Med. 188:1239.
69. + T cells. J. Exp. Med. 188:1849.